United Kingdom· GB-APID-189511000001109
Salazopyrin 500mg tablets
A sulfasalazine product containing sulfasalazine, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sulfasalazine is registered in 17 of 19 countries.
Countries holding a registration under ATC A07EC01 (sulfasalazine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Sulfasalazine · ATC A07EC01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sulfasalazine costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $0.43 in France to $1.35 in Switzerland — a ×3.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sulfasalazine · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.35
- IT Italy$0.68
- FR France$0.43
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sulfasalazine
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- A07EC01
- ATC class
- Sulfasalazine
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5012882008369
- gtin5013457027020
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
466 interactions on record for sulfasalazine.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulfasalazine · interactions on record
466 records
- 31 severe
- 183 moderate
- 7 minor
- 243 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sulfasalazine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAzulfidinePfizer Laboratories Div Pfizer Inc
- SwedenSalazopyrin 500 mg TablettPfizer AB
- CanadaPMS-SULFASALAZINE 500MG/TAB USPPHARMASCIENCE INC
- FinlandSalazopyrinPfizer Oy
- NorwaySalazopyrinPfizer ApS
- IcelandSalazopyrinPfizer ApS
- SwitzerlandSalazopyrin, TablettenPfizer AG
- SpainSALAZOPYRINA 500 MG COMPRIMIDOSPfizer S.L.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Salazopyrin
- Belgium · Salazopyrine Ec
- Bulgaria · Сулфасалазин Ен
- Cyprus · Salazidin Gr
- Czechia · Salazopyrin En, Sulfasalazin K-En
- Germany · Azulfidine, Azulfidine Ra
- Denmark · Salazopyrin, Salazopyrin Entabs
- Estonia · Salazopyrin En
- Spain · Salazopyrina
- Finland · Salazopyrin, Salazopyrin En
- France · Salazopyrine
- Greece · Salopyrine
- Croatia · Salazopyrin En, Sulfasalazin En Krka
- Hungary · Salazopyrin En
- Ireland · Salazopyrin, Salazopyrin En-Tabs
- Iceland · Salazopyrin, Salazopyrin En-Tabs
- Italy · Salazopyrin En
- Lithuania · Sulfasalazine Krka
- Luxembourg · Salazopyrine Ec
- Latvia · Sulfasalazine Krka
- Malta · Salazidin, Sulfasalazin Heyl
- Netherlands · Salazopyrine E.C., Salazopyrine Zetpil
- Norway · Salazopyrin En
- Poland · Salazopyrin En, Sulfasalazin En Krka
- Portugal · Salazopirina En
- Romania · Salazidin, Sulfasalazină En
- Sweden · Salazopyrin, Salazopyrin En
- Slovenia · Sulfasalazin Krka
- Slovakia · Sulfasalazin-En
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f34cdf14-3b55-418f-b9e5-d53404794db1 GET /v1/drugs/f34cdf14-3b55-418f-b9e5-d53404794db1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "189511000001109",
"desc": "Salazopyrin 500mg tablets (Pfizer Ltd)",
"form": "Oral tablet",
"vpid": "42298211000001101",
"source": "dmd",
"vtm_id": "777645000",
"strength": "500 mg",
"substance": "Sulfasalazine",
"ingredient": "Sulfasalazine",
"supplier_code": "2082201000001106"
}See everything about sulfasalazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.